TABLE OF CONTENTS
1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 OVERVIEW OF GLOBAL BURN CARE MARKET 21
1.4 LIMITATIONS 22
1.5 MARKETS COVERED 23
2 MARKET SEGMENTATION 26
2.1 MARKETS COVERED 26
2.2 GLOBAL BURN CARE MARKET: GEOGRAPHICAL SCOPE 27
2.3 YEARS CONSIDERED FOR THE STUDY 28
2.4 CURRENCY AND PRICING 28
2.5 DBMR TRIPOD DATA VALIDATION MODEL 29
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 32
2.7 DBMR MARKET POSITION GRID 33
2.8 DBMR VENDOR SHARE ANALYSIS 34
2.9 MULTIVARIATE MODELING 34
2.10 PRODUCTS LIFELINE CURVE 35
2.11 SECONDARY SOURCES 36
2.12 ASSUMPTIONS 36
3 MARKET OVERVIEW 37
3.1 DRIVERS 39
3.1.1 INCREASING INCIDENCE OF BURN INJURIES 39
3.1.2 GROWING ADVANCEMENTS IN BURN CARE PRODUCTS 40
3.1.3 RISING NUMBER OF EMERGENCY CENTERS AND BURN UNITS 40
3.1.4 INCREASING HEALTHCARE EXPENDITURE AND IMPROVING INFRASTRUCTURE 42
3.2 RESTRAINTS 44
3.2.1 HIGH COST OF ADVANCED TREATMENTS AND PRODUCTS 44
3.2.2 LACK OF REIMBURSEMENT 45
3.2.3 STRINGENT REGULATORY REQUIREMENTS 45
3.3 OPPORTUNITIES 46
3.3.1 RISING AWARENESS ON BURN CARE 46
3.3.2 STRATEGIC INITIATIVE BY MARKET PLAYER 46
3.3.3 RISING DEMAND FOR SKIN GRAFTS AND SUBSTITUTES 47
3.3.4 FAVORABLE GOVERNMENT INITIATIVES 48
?
3.4 CHALLENGES 48
3.4.1 STRONG COMPETITION AMONG MAJOR PLAYERS 48
3.4.2 PAIN AND TRAUMA ASSOCIATED WITH DRESSINGS 49
4 EXECUTIVE SUMMARY 50
5 PREMIUM INSIGHTS 53
6 GLOBAL BURN CARE MARKET, BY PRODUCT TYPE 55
6.1 OVERVIEW 56
6.2 ADVANCED BURN CARE PRODUCTS 57
6.2.1 FOAM DRESSINGS 58
6.2.2 HYDROGELS 58
6.2.3 FILM DRESSINGS 58
6.2.4 ALGINATES 58
6.2.5 WOUND CONTACT LAYER 58
6.2.6 HYDROCOLLOID 58
6.2.7 COLLAGEN 58
6.2.8 NANOCRYSTALLINE SILVER DRESSINGS 59
6.2.9 OTHERS 59
6.3 TRADITIONAL BURN CARE PRODUCTS 59
6.3.1 DRESSINGS 59
6.3.2 TAPES 59
6.4 BIOLOGICS 60
6.5 OTHER BURN CARE PRODUCTS 60
7 GLOBAL BURN CARE MARKET, BY DEPTH OF BURN 61
7.1 OVERVIEW 62
7.2 PARTIAL-THICKNESS BURNS 63
7.3 MINOR BURNS 63
7.4 FULL-THICKNESS BURNS 64
8 GLOBAL BURN CARE MARKET, BY BURN TYPE 65
8.1 OVERVIEW 66
8.2 THERMAL BURN 67
8.3 ELECTRICAL BURN 67
8.4 CHEMICAL BURN 68
8.5 RADIATION BURN 68
8.6 FRICTION BURN 69
8.7 OTHERS 69
9 GLOBAL BURN CARE MARKET, BY END USER 70
9.1 OVERVIEW 71
9.2 HOSPITALS 72
9.3 BURN CARE CENTRES 72
9.4 HOMECARE 73
9.5 CLINICS 73
9.6 OTHERS 74
10 GLOBAL BURN CARE MARKET, BY DISTRIBUTION CHANNEL 75
10.1 OVERVIEW 76
10.2 DIRECT TENDER 77
10.3 RETAIL 77
11 GLOBAL BURN CARE MARKET BY GEOGRAPHY 78
11.1 OVERVIEW 78
11.2 NORTH AMERICA 83
11.2.1 U.S. 89
11.2.2 CANADA 91
11.2.3 MEXICO 93
11.3 EUROPE 95
11.3.1 GERMANY 101
11.3.2 FRANCE 104
11.3.3 ITALY 106
11.3.4 U.K. 108
11.3.5 SWITZERLAND 110
11.3.6 NETHERLANDS 112
11.3.7 RUSSIA 114
11.3.8 TURKEY 116
11.3.9 SPAIN 118
11.3.10 BELGIUM 120
11.3.11 REST OF EUROPE 122
11.4 ASIA-PACIFIC 123
11.4.1 CHINA 129
11.4.2 JAPAN 131
11.4.3 INDIA 133
11.4.4 SOUTH KOREA 135
11.4.5 THAILAND 137
11.4.6 AUSTRALIA 139
11.4.7 MALAYSIA 141
11.4.8 SINGAPORE 143
11.4.9 INDONESIA 145
11.4.10 PHILIPPINES 147
11.4.11 REST OF ASIA-PACIFIC 149
11.5 SOUTH AMERICA 150
11.5.1 BRAZIL 156
11.5.2 REST OF SOUTH AMERICA 158
11.6 MIDDLE EAST AND AFRICA 159
11.6.1 SOUTH AFRICA 165
11.6.2 REST OF MIDDLE EAST AND AFRICA 167
12 GLOBAL BURN CARE MARKET, COMPANY LANDSCAPE 168
12.1 COMPANY SHARE ANALYSIS: GLOBAL 168
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 169
12.3 COMPANY SHARE ANALYSIS: EUROPE 170
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 171
13 COMPANY PROFILES 172
13.1 KCI LICENSING, INC. (A SUBSIDIARY OF ACELITY, INC) 172
13.1.1 COMPANY SNAPSHOT 172
13.1.2 COMPANY SHARE ANALYSIS 172
13.1.3 PRODUCT PORTFOLIO 173
13.1.4 RECENT DEVELOPMENTS 173
13.2 SMITH & NEPHEW 174
13.2.1 COMPANY SNAPSHOT 174
13.2.2 REVENUE ANALYSIS 174
13.2.3 COMPANY SHARE ANALYSIS 175
13.2.4 PRODUCT PORTFOLIO 175
13.2.5 RECENT DEVELOPMENT 176
13.3 MoLNLYCKE HEALTH CARE AB 177
13.3.1 COMPANY SNAPSHOT 177
13.3.2 COMPANY SHARE ANALUSIS 177
13.3.3 PRODUCT PORTFOLIO 177
13.3.4 RECENT DEVELOPMENTS 178
13.4 3M 179
13.4.1 COMPANY SNAPSHOT 179
13.4.2 REVENUE ANALYSIS 179
13.4.3 COMPANY SHARE ANALYSIS 180
13.4.4 PRODUCT PORTFOLIO 180
13.4.5 RECENT DEVELOPMENTS 181
?
13.5 CONVATEC GROUP PLC 182
13.5.1 COMPANY SNAPSHOT 182
13.5.2 REVENUE ANALYSIS 182
13.5.3 COMPANY SHARE ANALYSIS 183
13.5.4 PRODUCT PORTFOLIO 183
13.5.5 RECENT DEVELOPMENTS 185
13.6 ACELL INC. 186
13.6.1 COMPANY SNAPSHOT 186
13.6.2 PRODUCT PORTFOLIO 186
13.6.3 RECENT DEVELOPMENTS 186
13.7 ANIKA THERAPEUTICS, INC. 187
13.7.1 COMPANY SNAPSHOT 187
13.7.2 REVENUE ANALYSIS 187
13.7.3 PRODUCT PORTFOLIO 188
13.7.4 RECENT DEVELOPMENT 188
13.8 B. BRAUN MELSUNGEN AG 189
13.8.1 COMPANY SNAPSHOT 189
13.8.2 REVENUE ANALYSIS 189
13.8.3 PRODUCT PORTFOLIO 190
13.8.4 RECENT DEVELOPMENTS 190
13.9 CARDINAL HEALTH 191
13.9.1 COMPANY SNAPSHOT 191
13.9.2 REVENUE ANALYSIS 191
13.9.3 PRODUCT PORTFOLIO 192
13.9.4 RECENT DEVELOPMENT 192
13.10 COLOPLAST CORP 193
13.10.1 COMPANY SNAPSHOT 193
13.10.2 REVENUE ANALYSIS 193
13.10.3 PRODUCT PORTFOLIO 194
13.10.4 RECENT DEVELOPMENTS 195
13.11 DEROYAL INDUSTRIES, INC. 196
13.11.1 COMPANY SNAPSHOT 196
13.11.2 PRODUCT PORTFOLIO 196
13.11.3 RECENT DEVELOPMENTS 199
13.12 HOLLISTER INCORPORATED 200
13.12.1 COMPANY SNAPSHOT 200
13.12.2 PRODUCT PORTFOLIO 200
13.12.3 RECENT DEVELOPMENTS 201
?
13.13 INTEGRA LIFESCIENCES CORPORATION 202
13.13.1 COMPANY SNAPSHOT 202
13.13.2 REVENUE ANALYSIS 202
13.13.3 PRODUCT PORTFOLIO 203
13.13.4 RECENT DEVELOPMENTS 204
13.14 MEDLINE INDUSTRIES, INC. 205
13.14.1 COMPANY SNAPSHOT 205
13.14.2 PRODUCT PORTFOLIO 206
13.14.3 RECENT DEVELOPMENTS 209
13.15 PAUL HARTMANN AG 210
13.15.1 COMPANY SNAPSHOT 210
13.15.2 REVENUE ANALYSIS 210
13.15.3 PRODUCT PORTFOLIO 211
13.15.4 RECENT DEVELOPMENTS 212
13.16 POLYMEDICS INNOVATION GMBH 213
13.16.1 COMPANY SNAPSHOT 213
13.16.2 PRODUCT PORTFOLIO 213
13.16.3 RECENT DEVELOPMENT 213
14 QUESTIONNAIRE 214
15 RELATED REPORTS 218